Jongman Kim received his MD from the Korea University in 2000 and trained in the Department of Surgery, Korea University Medical Center until 2005. From 2008 to 2011, he worked as a fellow in the Transplantation Division, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine in Seoul, Korea. He studied solid organ transplantation and HCC in those periods. He completed his Ph.D. (Korea University, 2009), which subject was immunotherapy using a 4-1BB antibody against cancer. As a professor, his career has continued in the Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine until now (2023). He operated on laparoscopic liver resection in liver malignancy and living liver donor and has studied for HCC hepatectomy patients. He has performed many prospective clinical trials, and international multicenter registration studies and thus published many papers. In addition, he has operated on living or deceased donor liver transplantation. His focusing projects were minimal invasive surgical techniques, surgical techniques of liver transplantation, ABO-incompatibility, HCC, and immunosuppression in liver transplantation. He published approximately 330 articles related to liver transplantation and/or HCC in the Journal of Hepatology, Hepatology, Annals of Surgery, British Journal of Surgery, Liver Transplantation, and Transplantation.